Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (91-100 of 342) with videos related to

Pageof 35
Sort By:
Nature Reviews. Neurology|January 14, 2017
Treatment decisions in multiple sclerosis - insights from real-world observational studiesMaria Trojano, Mar Tintore, Xavier Montalban, et al.
Journal of the Neurological Sciences|July 11, 2020
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomideLuca Bollo, Tommaso Guerra, Davide Fiore Bavaro, et al.
Journal of Cellular and Molecular Medicine|October 22, 2017
Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis opticaStefania Rosito, Grazia Paola Nicchia, Claudia Palazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cancer in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2020
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational ProgramHeinz Wiendl, Tim Spelman, Helmut Butzkueven, et al.
Plos One|November 22, 2013
Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityFrancesco Pisani, Angelo Sparaneo, Carla Tortorella, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 28, 2008
A case report of double filtration plasmapheresis in an acute episode of multiple sclerosisAlfonso Ramunni, Francesca De Robertis, Paola Brescia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2016
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Patrick Vermersch, Thomas Berger, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2017
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort studyLudwig Kappos, Helmut Butzkueven, Heinz Wiendl, et al.
Pageof 35

Showing results (91-100 of 342) with videos related to

Sort By:
Pageof 35
Nature Reviews. Neurology|January 14, 2017
Treatment decisions in multiple sclerosis - insights from real-world observational studiesMaria Trojano, Mar Tintore, Xavier Montalban, et al.
Journal of the Neurological Sciences|July 11, 2020
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomideLuca Bollo, Tommaso Guerra, Davide Fiore Bavaro, et al.
Journal of Cellular and Molecular Medicine|October 22, 2017
Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis opticaStefania Rosito, Grazia Paola Nicchia, Claudia Palazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cancer in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2020
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational ProgramHeinz Wiendl, Tim Spelman, Helmut Butzkueven, et al.
Plos One|November 22, 2013
Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityFrancesco Pisani, Angelo Sparaneo, Carla Tortorella, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 28, 2008
A case report of double filtration plasmapheresis in an acute episode of multiple sclerosisAlfonso Ramunni, Francesca De Robertis, Paola Brescia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2016
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Patrick Vermersch, Thomas Berger, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2017
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort studyLudwig Kappos, Helmut Butzkueven, Heinz Wiendl, et al.
Pageof 35